Madrigal says liver disease candidate improved key patient outcomes in late-stage study
31 Janeiro 2022 - 9:36AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Madrigal Pharmaceuticals (NASDAQ:MDGL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Madrigal Pharmaceuticals (NASDAQ:MDGL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024